Biologic Patents Expiring in 2042
✉ Email this page to a colleague
Biologic Patents With Estimated Expirations in 2042
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,049,652 | 2042-12-12 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,054,758 | 2042-12-15 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,060,590 | 2042-12-19 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,104,184 | 2042-12-19 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,123,035 | 2042-12-19 |
| Akorn, Inc. | HYDASE | hyaluronidase | Injection | 021716 | October 25, 2005 | 12,280,095 | 2042-08-25 |
| Takeda Pharmaceuticals U.s.a., Inc. | VPRIV | velaglucerase alfa | For Injection | 022575 | February 26, 2010 | 11,702,580 | 2042-01-04 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
